Gapping down
In reaction to earnings/guidance:
- CMBM -16.3%, ERIC -5.4%, WFC -3.3%, RENT -1.4%
Other news:
- PTGX -28.9% (received letter from FDA indicating intent to rescind Breakthrough Therapy Designation for rusfertide)
- OCX -6.3% (prices offering of common stock and warrants)
- EVLO -5.8% (provides updated guidance on advancing clinical inflammation programs)
- DWAC -5.1% (trading lower in response to TWTR/Elon Musk news)
- BABA -2.3% (Key China watchdog group among agencies involved in Ant Group investigation according to Bloomberg)
- EGO -1.4% (reports Q1 preliminary gold production)
- GPC -1.1% (announced acquisition of Lausan Group)
- BTG -1% (reports Q1 gold production 5% above budget)
Analyst comments:
- APLS -3.7% (downgraded to Sell from Neutral at ROTH Capital)
- STX -3.1% (downgraded to Negative from Neutral at Susquehanna)
- BBBY -2% (downgraded to Market Perform from Outperform at Telsey Advisory Group)
- CVLG -1.9% (downgraded to Market Perform from Outperform at Cowen)